Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Guelph

$25,000.00

Mutagenicity assay system based on recombinant human enzymes

EF 2010-11

Résumé
Bacterial mutagenicity assays are an important tool for testing environmental samples, new chemical and pharmaceutical entities, and other materials, for potential genetic toxicity. The purpose of such testing is to ensure that new drugs or other chemicals that could be used in consumer products or released into the environment do not present a risk of cancer or genetic damage. Our goal is to develop and commercialize an improved system for these assays, in which recombinant human P450 enzymes, expressed in the bacteria, can carry out the metabolism of the test chemicals. This innovation will enable even non-specialized laboratories to perform tests which should have a greatly improved relevance to assessment of human health risk. Our new approach will improve upon mutagenicity tests currently on the market, which incorporate ""S9"" fractions derived from rats or hamsters administered PCBs or other toxic agents. Our system will be based on the Escherichia coli lacZ reversion mutagenicity assay and will be implemented in a ""micro-plate"" format, providing laboratories worldwide with an improved screen for mutagenic activity providing a better correlation to human health risk.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
399622-2010
Name nom
Josephy, David
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
406
Area of application group en
Environment
Area of application group fr
Environnement
Area of application en
Pollutants and toxic agents (waste, use 902)
Area of application fr
Polluants et agents toxiques (déchets, utiliser 902)
Research subject code
6403
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Toxicology
Research subject fr
Toxicologie
Partie
1
Nb partie
1
Application title
Mutagenicity assay system based on recombinant human enzymes
Keyword
NSERC
Application summary
Bacterial mutagenicity assays are an important tool for testing environmental samples, new chemical and pharmaceutical entities, and other materials, for potential genetic toxicity. The purpose of such testing is to ensure that new drugs or other chemicals that could be used in consumer products or released into the environment do not present a risk of cancer or genetic damage. Our goal is to develop and commercialize an improved system for these assays, in which recombinant human P450 enzymes, expressed in the bacteria, can carry out the metabolism of the test chemicals. This innovation will enable even non-specialized laboratories to perform tests which should have a greatly improved relevance to assessment of human health risk. Our new approach will improve upon mutagenicity tests currently on the market, which incorporate ""S9"" fractions derived from rats or hamsters administered PCBs or other toxic agents. Our system will be based on the Escherichia coli lacZ reversion mutagenicity assay and will be implemented in a ""micro-plate"" format, providing laboratories worldwide with an improved screen for mutagenic activity providing a better correlation to human health risk.